全文获取类型
收费全文 | 304106篇 |
免费 | 21621篇 |
国内免费 | 1343篇 |
专业分类
耳鼻咽喉 | 3438篇 |
儿科学 | 7834篇 |
妇产科学 | 5590篇 |
基础医学 | 39529篇 |
口腔科学 | 5464篇 |
临床医学 | 30431篇 |
内科学 | 64168篇 |
皮肤病学 | 4062篇 |
神经病学 | 29331篇 |
特种医学 | 10115篇 |
外国民族医学 | 15篇 |
外科学 | 47247篇 |
综合类 | 4217篇 |
现状与发展 | 1篇 |
一般理论 | 383篇 |
预防医学 | 26176篇 |
眼科学 | 7669篇 |
药学 | 20159篇 |
6篇 | |
中国医学 | 417篇 |
肿瘤学 | 20818篇 |
出版年
2023年 | 1533篇 |
2022年 | 2783篇 |
2021年 | 6338篇 |
2020年 | 3771篇 |
2019年 | 6129篇 |
2018年 | 6994篇 |
2017年 | 5191篇 |
2016年 | 5740篇 |
2015年 | 6721篇 |
2014年 | 10065篇 |
2013年 | 14015篇 |
2012年 | 21171篇 |
2011年 | 22356篇 |
2010年 | 12527篇 |
2009年 | 11236篇 |
2008年 | 19755篇 |
2007年 | 20721篇 |
2006年 | 20529篇 |
2005年 | 20612篇 |
2004年 | 19481篇 |
2003年 | 18053篇 |
2002年 | 16990篇 |
2001年 | 2541篇 |
2000年 | 1932篇 |
1999年 | 2837篇 |
1998年 | 3737篇 |
1997年 | 3132篇 |
1996年 | 2703篇 |
1995年 | 2586篇 |
1994年 | 2189篇 |
1993年 | 1974篇 |
1992年 | 1591篇 |
1991年 | 1495篇 |
1990年 | 1283篇 |
1989年 | 1253篇 |
1988年 | 1233篇 |
1987年 | 1200篇 |
1986年 | 1191篇 |
1985年 | 1242篇 |
1984年 | 1660篇 |
1983年 | 1499篇 |
1982年 | 1842篇 |
1981年 | 1784篇 |
1980年 | 1610篇 |
1979年 | 945篇 |
1978年 | 1017篇 |
1977年 | 901篇 |
1976年 | 791篇 |
1975年 | 675篇 |
1974年 | 691篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
21.
22.
23.
24.
Hanna Lee Mary K. Tan Andrew T. Yan Paul Angaran Paul Dorian Claudia Bucci Jean C. Gregoire Alan D. Bell Martin S. Green Peter L. Gross Allan Skanes Charles R. Kerr L. Brent Mitchell Jafna L. Cox Vidal Essebag Brett Heilbron Krishnan Ramanathan Carl Fournier Shaun G. Goodman 《The Canadian journal of cardiology》2019,35(2):160-168
Background
Physicians treating nonvalvular atrial fibrillation (AF) assess stroke and bleeding risks when deciding on anticoagulation. The agreement between empirical and physician-estimated risks is unclear. Furthermore, the association between patient and physician sex and anticoagulation decision-making is uncertain.Methods
We pooled data from 2 national primary care physician chart audit databases of patients with AF (Facilitating Review and Education to Optimize Stroke Prevention in Atrial Fibrillation and Coordinated National Network to Engage Physicians in the Care and Treatment of Patients with Atrial Fibrillation Chart Audit) with a combined 1035 physicians (133 female, 902 male) and 10,927 patients (4567 female and 6360 male).Results
Male physicians underestimated stroke risk in female patients and overestimated risk in male patients. Female physicians estimated stroke risk well in female patients but underestimated the risk in male patients. Risk of bleeding was underestimated in all. Despite differences in risk assessment by physician and patient sex, > 90% of patients received anticoagulation across all subgroups. There was modest agreement between physician estimated and calculated (ie, CHADS2 score) stroke risk: Kappa scores were 0.41 (0.35-0.47) for female physicians and 0.34 (0.32-0.36) for male physicians.Conclusions
Our study is the first to examine the association between patient and physician sex influences and stroke and bleeding risk estimation in AF. Although there were differences in agreement between physician estimated stroke risk and calculated CHADS2 scores, these differences were small and unlikely to affect clinical practice; further, despite any perceived differences in the accuracy of risk assessment by sex, most patients received anticoagulation. 相似文献25.
M. Tobias Heinrichs George L. Drusano David L. Brown Michael S. Maynard Sherwin K.B. Sy Kenneth H. Rand Charles A. Peloquin Arnold Louie Hartmut Derendorf 《International journal of antimicrobial agents》2019,53(3):275-283
Introduction
There is an urgent need for new anti-tuberculosis (TB) drugs and optimization of current TB treatment. Moxifloxacin and linezolid are valuable options for the treatment of drug-resistant TB; however, it is crucial to find a dose at which these drugs not only show high efficacy but also suppress the development of further drug resistance.Methods
Activity of moxifloxacin and linezolid against Mycobacterium tuberculosis was studied in the hollow-fiber infection model system in log-phase growth under neutral pH and slow growth in an acidic environment. Doses that achieved maximum bacterial kill while suppressing the emergence of drug resistance were determined. Through Monte Carlo simulations the quantitative output of this in vitro study was bridged to the human patient population to inform optimal dosage regimens while accounting for clinical minimum inhibitory concentration (MIC) distributions.Results and Discussion
Moxifloxacin activity was significantly decreased in an acidified environment. The loss of activity was compensated by accumulation of the drug in TB lung lesions; therefore, moderate efficacy can be expected. Moxifloxacin 800 mg/day is the dose that most likely leads to resistance suppression while exerting maximum bacterial kill. Linezolid demonstrated very good activity even at a reduced pH. Linezolid 900 mg once-daily (QD) is likely to achieve a maximum killing effect and prevent the emergence of drug resistance; 600 mg QD in a robust drug regimen may have similar potential. 相似文献26.
27.
28.
29.
David Jutri? Domagoj ?iki? Almo? Boro? Dyana Odeh Romana Gra?an An?elo Beleti? Irena Landeka Jur?evi? 《Arhiv za higijenu rada i toksikologiju》2023,74(3):218
Valproate is known to disturb the kidney function, and high doses or prolonged intake may cause serum ion imbalance, kidney tubular acidosis, proteinuria, hyperuricosuria, polyuria, polydipsia, and dehydration. The aim of this in vivo study was to see whether naringin would counter the adverse effects of high-dose valproate in C57Bl/6 mice and to which extent. As expected, valproate (150 mg/kg bw a day for 10 days) caused serum hyperkalaemia, more in male than female mice. Naringin reversed (25 mg/kg bw a day for 10 days) the hyperkalaemia and activated antioxidative defence mechanisms (mainly catalase and glutathione), again more efficiently in females. In males naringin combined with valproate was not as effective and even showed some prooxidative effects.KEY WORDS: calcium, catalase, hyperkalaemia, malondialdehyde, oxidative stress, potassium, sodium, superoxide dismutase 相似文献
30.